RG
TMO icon

Renaissance Group’s Thermo Fisher Scientific TMO Stock Holding History

Renaissance Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Sell
556
-197
-26% -$94.6K 0.01% 210
2026
Q1 		$370K Sell
753
-850
-53% -$461K 0.02% 192
2025
Q4 		$929K Sell
1,603
-9
-0.6% -$5.09K 0.04% 162
2025
Q3 		$782K Sell
1,612
-50
-3% -$23.3K 0.03% 169
2025
Q2 		$674K Sell
1,662
-58,813
-97% -$24.6M 0.03% 174
2025
Q1 		$30.1M Buy
60,475
+5,531
+10% +$3M 1.33% 33
2024
Q4 		$28.6M Buy
54,944
+1,819
+3% +$1M 1.18% 45
2024
Q3 		$32.9M Sell
53,125
-349
-0.7% -$207K 1.35% 40
2024
Q2 		$29.6M Sell
53,474
-349
-0.6% -$200K 1.15% 49
2024
Q1 		$31.3M Buy
53,823
+442
+0.8% +$248K 1.18% 50
2023
Q4 		$28.3M Buy
53,381
+1,337
+3% +$647K 1.17% 49
2023
Q3 		$26.3M Buy
52,044
+453
+0.9% +$241K 1.2% 46
2023
Q2 		$26.9M Buy
51,591
+576
+1% +$311K 1.16% 48
2023
Q1 		$29.4M Sell
51,015
-134
-0.3% -$75.5K 1.35% 31
2022
Q4 		$28.2M Sell
51,149
-26
-0.1% -$13.8K 1.38% 26
2022
Q3 		$26M Sell
51,175
-170
-0.3% -$95.1K 1.4% 21
2022
Q2 		$27.9M Buy
51,345
+241
+0.5% +$133K 1.44% 11
2022
Q1 		$30.2M Buy
51,104
+8
+0% +$4.6K 1.36% 26
2021
Q4 		$34.1M Sell
51,096
-1,240
-2% -$774K 1.39% 23
2021
Q3 		$29.9M Sell
52,336
-11,096
-17% -$6.09M 1.29% 30
2021
Q2 		$32M Sell
63,432
-939
-1% -$443K 1.34% 17
2021
Q1 		$29.4M Sell
64,371
-2,600
-4% -$1.24M 1.24% 32
2020
Q4 		$31.2M Sell
66,971
-7,204
-10% -$3.38M 1.34% 16
2020
Q3 		$32.8M Sell
74,175
-4,814
-6% -$1.99M 1.51% 8
2020
Q2 		$28.6M Sell
78,989
-5,788
-7% -$1.94M 1.36% 14
2020
Q1 		$24M Sell
84,777
-5,349
-6% -$1.69M 1.34% 10
2019
Q4 		$29.3M Sell
90,126
-3,087
-3% -$936K 1.2% 22
2019
Q3 		$27.1M Sell
93,213
-3,007
-3% -$861K 1.15% 29
2019
Q2 		$28.3M Sell
96,220
-3,119
-3% -$859K 1.15% 26
2019
Q1 		$27.2M Buy
+99,339
New +$24.7M 1.09% 33

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Renaissance Group's TMO Position: Q2 2026 in Review

Renaissance Group reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q2 2026, selling an estimated $94.6K and leaving 556 shares worth $279K. The position accounts for 0.01% of the portfolio, ranked #210.

Renaissance Group first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. The position peaked at $34.1M in Q4 2021. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Renaissance Group held 556 shares of Thermo Fisher Scientific worth $279K as of Q2 2026.
  • Renaissance Group sold 197 Thermo Fisher Scientific shares in Q2 2026, an estimated $94.6K.
  • Thermo Fisher Scientific made up 0.01% of Renaissance Group's portfolio in Q2 2026, its #210 holding.
  • Renaissance Group first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
  • Renaissance Group's Thermo Fisher Scientific position peaked at $34.1M in Q4 2021.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.